Free Access
Med Sci (Paris)
Volume 31, Number 12, Décembre 2015
Page(s) 1066 - 1069
Section Nouvelles
Published online 16 December 2015
  1. Hacein-Bey-Abina S, Gaspar HB, Blondeau J, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA 2015 ; 313 : 1550–1563. [Google Scholar]
  2. Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol 2011 ; 18 : 42–48. [CrossRef] [PubMed] [Google Scholar]
  3. Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol 2010 ; 10 : 182–192. [CrossRef] [PubMed] [Google Scholar]
  4. Pai SY, Notarangelo LD. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. Immunol Allergy Clin North Am 2010 ; 30 : 179–194. [CrossRef] [PubMed] [Google Scholar]
  5. Kaufmann KB, Buning H, Galy A, et al. Gene therapy on the move. EMBO Mol Med 2013 ; 5 : 1642–1661. [CrossRef] [PubMed] [Google Scholar]
  6. Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008 ; 118 : 3132–3142. [CrossRef] [PubMed] [Google Scholar]
  7. Charrier S, Dupré L, Scaramuzza S, et al. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther 2007 ; 14 : 415–428. [CrossRef] [PubMed] [Google Scholar]
  8. Modlich U, Navarro S, Zychlinski D, et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009 ; 17 : 1919–1928. [CrossRef] [PubMed] [Google Scholar]
  9. Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013 ; 341 : 1233151. [CrossRef] [PubMed] [Google Scholar]
  10. Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome: long-term efficacy and genotoxicity. Sci Transl Med 2014 ; 6 : 227ra33. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.